|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease costs | |||||
| Share-based compensation | |||||
| Provision for credit losses on accounts receivable | |||||
| Provision for credit losses on investments | |||||
| Deferred income taxes, net | |||||
| Gain on extinguishment of debt, net | |||||
| Loss on sale of businesses | |||||
| Lease asset impairments and other charges | |||||
| Goodwill impairment | |||||
| Changes in fair value of contingent consideration | |||||
| Unrealized loss (gain) on short-term investments held at the reporting date | |||||
| Loss (income) from equity method investments | |||||
| (Gain) loss on investment, net | |||||
| Other | |||||
| Decrease (increase) in: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Increase (decrease) in: | |||||
| Accounts payable and income taxes payable | |||||
| Deferred revenue | |||||
| Accrued liabilities and other current liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds on sale of available-for-sale investments | |||||
| Acquisitions, net of cash received | |||||
| Purchase of equity investments | |||||
| Proceeds from sale of equity investments | |||||
| Investment in available-for-sale securities | |||||
| Proceeds from sale of equity method investment | |||||
| Distribution from equity method investment | |||||
| Proceeds from sale of businesses, net of cash divested | |||||
| Proceeds from divestiture of discontinued operations | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from bridge loan | |||||
| Payment of debt | |||||
| Proceeds from term loan | |||||
| Debt extinguishment costs | |||||
| Repurchase of common stock | |||||
| Issuance of common stock under employee stock purchase plan | |||||
| Proceeds from exercise of stock options | |||||
| Deferred payments for acquisitions | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at beginning of year associated with discontinued operations | |||||
| Cash and cash equivalents at beginning of year associated with continuing operations | |||||
| Cash and cash equivalents at end of year | |||||
| Cash and cash equivalents at end of year associated with discontinued operations | |||||
Loading...